Effect of Cyclosporine and Rifampin on the Pharmacokinetics of Macitentan, a Tissue-Targeting Dual Endothelin Receptor Antagonist

Macitentan is a dual endothelin receptor antagonist under phase 3 investigation in pulmonary arterial hypertension. We investigated the effect of cyclosporine (Cs) and rifampin on the pharmacokinetics of macitentan and its metabolites ACT-132577 and ACT-373898 in healthy male subjects. In addition,...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Bruderer, Shirin, Äänismaa, Päivi, Homery, Marie-Claude, Häusler, Stephanie, Landskroner, Kyle, Sidharta, Patricia N., Treiber, Alexander, Dingemanse, Jasper
Format: Artigo
Jezik:Inglês
Izdano: Springer US 2011
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3282010/
https://ncbi.nlm.nih.gov/pubmed/22189899
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1208/s12248-011-9316-3
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items